InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Broadfoot Jill Marie, Chief Financial Officer. Insider active across 3 companies, notably Acelrx Pharmaceuticals INC. Cumulatively, 4 disclosures have been logged. Total volume traded: €23k. The latest transaction was disclosed on 13 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€11,3451,923 shares@ €5.8995100.0% of flow
Common stock
SEC:0001209191-22-003419·
Ideal exit: 10 Oct 2022 (T+270)
€11,3451,923 shares@ €5.89950.015% mcap100.0% of flow
Common stock
SEC:0001209191-22-003419:0·
Ideal exit: 10 Oct 2022 (T+270)
015,000 shares0
Common Stock
SEC:0001209191-21-066559·
015,000 shares0
Common Stock
SEC:0001209191-21-066559:0·
4 of 4 declarations
About Broadfoot Jill Marie
Jill Marie Broadfoot is a Director and Chief Financial Officer at AcelRx Pharmaceuticals Inc and aTYR Pharma Inc. She oversees the financial operations of these companies, including budgeting and risk management. AcelRx Pharmaceuticals and aTYR Pharma are biopharmaceutical companies. Jill's expertise in finance is essential to ensure the financial health of these companies.
